Dorothee Herlyn Selected Research

Dorothee Herlyn Research Topics

Disease

27	Neoplasms (Cancer) 01/2017 - 04/2002
14	Melanoma (Melanoma, Malignant) 01/2017 - 03/2003
6	Colorectal Neoplasms (Colorectal Cancer) 09/2010 - 04/2002
5	Breast Neoplasms (Breast Cancer) 04/2007 - 06/2004
4	Glioma (Gliomas) 04/2007 - 04/2003
3	Carcinoma (Carcinomatosis) 09/2010 - 05/2006
2	Neoplasm Metastasis (Metastasis) 01/2016 - 04/2009
2	Ovarian Neoplasms (Ovarian Cancer) 06/2011 - 10/2003
1	Ovarian Epithelial Carcinoma 06/2011
1	Disease Progression 06/2011
1	Rectal Neoplasms (Rectal Cancer) 09/2010
1	Lymphopenia (Lymphocytopenia) 04/2009
1	Glioblastoma (Glioblastoma Multiforme) 04/2009
1	Neuroblastoma 04/2009
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 04/2009
1	Brain Neoplasms (Brain Tumor) 08/2006
1	Ulcerative Colitis 05/2006
1	Adenocarcinoma 04/2005
1	Circulating Neoplastic Cells 12/2004
1	Female Genital Diseases 10/2003
1	Colonic Neoplasms (Colon Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 01/2015 - 04/2002
9	VaccinesIBA 04/2009 - 04/2002
9	AntibodiesIBA 07/2008 - 04/2002
6	ChemokinesIBA 03/2011 - 05/2005
5	Proteins (Proteins, Gene)FDA Link 06/2011 - 09/2003
5	Chemokine ReceptorsIBA 04/2009 - 05/2005
4	Peptides (Polypeptides)IBA 01/2015 - 03/2006
4	Epithelial Cell Adhesion MoleculeIBA 06/2011 - 04/2002
4	Monoclonal AntibodiesIBA 04/2009 - 04/2002
3	CytokinesIBA 04/2009 - 04/2003
3	LigandsIBA 10/2006 - 05/2005
3	Anti-Idiotypic AntibodiesIBA 03/2003 - 04/2002
2	AutoantibodiesIBA 06/2011 - 10/2003
2	CollagenIBA 03/2011 - 05/2005
2	GD2 gangliosideIBA 07/2008 - 03/2003
2	Trastuzumab (Herceptin)FDA Link 11/2006 - 06/2004
2	ErbB Receptors (EGF Receptor)IBA 08/2006 - 11/2004
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2006 - 11/2005
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	HLA-B57 antigenIBA 01/2015
1	PlatinumIBA 06/2011
1	CCR2 ReceptorsIBA 03/2011
1	HLA-A1 Antigen (HLA A1 Antigen)IBA 09/2010
1	NucleophosminIBA 09/2010
1	saponin QA-21V1 (QS21)IBA 07/2008
1	Immunoglobulin M (IgM)IBA 07/2008
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 07/2008
1	Immunoglobulin G (IgG)IBA 07/2008
1	Histocompatibility Antigens Class IIIBA 04/2007
1	rat ribosomal protein L8IBA 04/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2007
1	Chemokine CXCL11IBA 03/2007
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2006
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2006
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2006
1	epidermal growth factor receptor VIIIIBA 08/2006
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 05/2006
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2006
1	CCR ReceptorsIBA 02/2006
1	CC ChemokinesIBA 02/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2005
1	CXC ChemokinesIBA 05/2005
1	Collagen Type I (Type I Collagen)IBA 05/2005
1	Chemokine CXCL12IBA 05/2005
1	IntegrinsIBA 04/2005
1	TetraspaninsIBA 04/2005
1	Protein Kinase CIBA 04/2005
1	Epidermal Growth Factor (EGF)IBA 11/2004
1	Biomarkers (Surrogate Marker)IBA 06/2004
1	Tumor Biomarkers (Tumor Markers)IBA 10/2003
1	Messenger RNA (mRNA)IBA 10/2003
1	Interleukin-2 (IL2)IBA 09/2003
1	gamma-AIBA 04/2003
1	ElementsIBA 04/2003
1	HLA-DR7 Antigen (HLA DR7 Antigen)IBA 04/2003
1	GD3 ganglioside (GD(3))IBA 03/2003
1	GangliosidesIBA 03/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2002
1	EpitopesIBA 06/2002
1	Recombinant ProteinsIBA 04/2002

Therapy/Procedure

10	Therapeutics 01/2017 - 04/2003
4	Immunotherapy 06/2013 - 07/2008
2	Drug Therapy (Chemotherapy) 06/2011 - 04/2009
1	Mastectomy (Mammectomy) 12/2004